Company Filing History:
1 out of 51 
1 out of 50 
1 out of 50 
Years Active: 2022
Title: Innovations in Drug Delivery: The Contributions of Abdulmohsen Alkushi
Introduction
Abdulmohsen Alkushi is a notable inventor based in Riyadh, Saudi Arabia. He has made significant contributions to the field of drug delivery systems, particularly in the development of innovative drug carriers. His work focuses on enhancing the efficacy of anticancer therapies through advanced materials.
Latest Patents
One of Abdulmohsen Alkushi's key patents is for an iron oxide mesoporous microparticle drug carrier. This magnetic microparticle drug carrier comprises mesoporous iron oxide and has an average diameter ranging from 0.5 to 1.2 µm. The drug carrier features a BET surface area between 50 and 300 m²/g, along with a pore volume of 0.15 to 0.65 cm³/g. The design utilizes a hard mesoporous silica template that is completely removed after the deposition of iron oxide. This innovative drug carrier can be loaded with high amounts of both hydrophilic anticancer chemotherapeutic drugs and hydrophobic hormonal anticancer drugs, allowing for controlled release within cancerous cells. Compared to free drugs, this microparticle carrier demonstrates enhanced drug accumulation in tumor tissues, effectively penetrating tumor regions and targeting tumor cells. The carriers are designed to entrap and release various anticancer drugs in a controlled manner, facilitating synergistic combinatorial chemo/hormonal cancer therapy.
Career Highlights
Abdulmohsen Alkushi has worked with prominent organizations such as National Guard Health Affairs and King Saud Bin Abdulaziz University for Health Sciences. His experience in these institutions has contributed to his expertise in health sciences and drug delivery systems.
Collaborations
He has collaborated with notable colleagues, including Kheireddine El-Boubbou and Rizwan Ali, to advance research in drug delivery technologies.
Conclusion
Abdulmohsen Alkushi's innovative work in the development of drug carriers represents a significant advancement in cancer treatment methodologies. His contributions are paving the way for more effective therapeutic options in the fight against cancer.